Search Results - "Ishiguro, Yukari"

Androgen receptor mRNA expression is a predictor for recurrence-free survival in non-muscle invasive bladder cancer by Yasui, Masato, Kawahara, Takashi, Izumi, Koji, Yao, Masahiro, Ishiguro, Yukari, Ishiguro, Hitoshi, Uemura, Hiroji, Miyoshi, Yasuhide

“…Non-muscular invasive bladder cancer (NMIBC) has a high risk of recurrence. As androgen receptor (AR) reportedly affects bladder cancer, we assessed the…”
Get full text

Epidermal growth factor receptor tyrosine kinase inhibition up-regulates interleukin-6 in cancer cells and induces subsequent development of interstitial pneumonia by Ishiguro, Yukari, Ishiguro, Hitoshi, Miyamoto, Hiroshi

“…Acute interstitial pneumonia is one of serious side effects of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) treatment, while it…”
Get full text

Expression of receptor activator of nuclear factor kappa B ligand in bladder cancer by Ohtaka, Mari, Kawahara, Takashi, Ishiguro, Yukari, Sharma, Meenal, Yao, Masahiro, Miyamoto, Hiroshi, Uemura, Hiroji

Get full text

PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer by Kawahara, Takashi, Ishiguro, Yukari, Ohtake, Shinji, Kato, Ikuma, Ito, Yusuke, Ito, Hiroki, Makiyama, Kazuhide, Kondo, Keiichi, Miyoshi, Yasuhide, Yumura, Yasushi, Hayashi, Narihiko, Hasumi, Hisashi, Osaka, Kimito, Muraoka, Kentaro, Izumi, Koji, Teranishi, Jun-Ichi, Uemura, Hiroji, Yao, Masahiro, Nakaigawa, Noboru

“…Bladder cancers have been characterized as a tumor group in which the immunological response is relatively well preserved. Programmed death ligand 1 (PD-L1,…”
Get full text

Restoration of BRAK / CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinoma by Ozawa, Shigeyuki, Kato, Yasumasa, Ito, Shin, Komori, Reika, Shiiki, Naoto, Tsukinoki, Keiichi, Ozono, Satoru, Maehata, Yojiro, Taguchi, Takahide, Imagawa‐Ishiguro, Yukari, Tsukuda, Mamoru, Kubota, Eiro, Hata, Ryu‐Ichiro

“…Clinical efficacy of gefitinib (ZD1839, Iressa), which is an inhibitor specific for epidermal growth factor (EGF) receptor tyrosine kinase, has been shown in…”
Get full text

Chemopreventive effects of angiotensin II receptor type 2 agonist on prostate carcinogenesis by the down-regulation of the androgen receptor by Ito, Yusuke, Naiki-Ito, Aya, Kato, Hiroyuki, Suzuki, Shugo, Kuno, Toshiya, Ishiguro, Yukari, Takahashi, Satoru, Uemura, Hiroji

“…We recently reported that angiotensin II receptor blockers (ARBs) have chemopreventive and chemotherapeutic potential against prostate cancer via the reduction…”
Get full text

Effects of antioxidant co‐supplementation therapy on spermatogenesis dysfunction in relation to the basal oxidation–reduction potential levels in spermatozoa: A pilot study by Yamasaki, Kazumitsu, Uchida, Masahiro, Watanabe, Noriko, Ihana, Tatsuji, Ishiguro, Yukari, Kuroda, Shinnosuke, Takeshima, Teppei, Yumura, Yasushi, Mieno, Makiko, Yoshida, Kaoru, Iwamoto, Teruaki, Nishiyama, Hiroyuki

“…Purpose In this pilot study, the authors compared the effects of antioxidant co‐supplementation therapy and methylcobalamin therapy in patients with impaired…”
Get full text

Angiotensin II Induces Oxidative Stress in Prostate Cancer by Uemura, Hiroji, Ishiguro, Hitoshi, Ishiguro, Yukari, Hoshino, Kouji, Takahashi, Satoru, Kubota, Yoshinobu

“…Angiotensin II has been shown to be a cytokine especially acting as a growth factor. A local renin-angiotensin system has been identified in the prostate…”
Get full text

Correlation between FDG-PET findings and GLUT1 expression in salivary gland pleomorphic adenomas by Horiuchi, Choichi, Tsukuda, Mamoru, Taguchi, Takahide, Ishiguro, Yukari, Okudera, Koji, Inoue, Tomio

“…Objective One reason for the difficulty in accurate preoperative pathological diagnosis of major salivary gland tumors with fluoro-2-deoxy- D -glucose-positron…”
Get full text

Expression of PD‐L1 and CTLA‐4 in female urethral carcinoma by Ninomiya, Sahoko, Kawahara, Takashi, Mochizuki, Taku, Ishiguro, Yukari, Miyoshi, Yasuhide, Otani, Masako, Yao, Masahiro, Miyamoto, Hiroshi, Uemura, Hiroji

“…Introduction Although the tumors are often easily detected, a considerable number of patients with female urethral carcinoma are diagnosed in an advance stage…”
Get full text

aPKCλ/ι promotes growth of prostate cancer cells in an autocrine manner through transcriptional activation of interleukin-6 by Ishiguro, Hitoshi, Akimoto, Kazunori, Nagashima, Yoji, Kojima, Yasuyuki, Sasaki, Takeshi, Ishiguro-Imagawa, Yukari, Nakaigawa, Noboru, Ohno, Shigeo, Kubota, Yoshinobu, Uemura, Hiroji

“…Understanding the mechanism by which hormone refractory prostate cancer (HRPC) develops remains a major issue. Alterations in HRPC include androgen receptor…”
Get full text

Examination of the optimal condition on the in vitro sensitivity to telomelysin in head and neck cancer cell lines by Sakakibara, Atsuko, Tsukuda, Mamoru, Kondo, Norio, Ishiguro, Yukari, Kimura, Machiko, Fujita, Kyoko, Takahashi, Hideaki, Matsuda, Hideki

“…Abstract Objective Telomelysin (OBP-301) is a telomerase-specific replication-competent adenovirus with a human telomerase reverse transcriptase (hTERT)…”
Get full text

Antitumor effects of Nafamostat mesilate on head and neck squamous cell carcinoma by Yamashita, Yukiko, Ishiguro, Yukari, Sano, Daisuke, Kimura, Machiko, Fujita, Kyoko, Yoshida, Takafumi, Horiuchi, Choichi, Taguchi, Takahide, Matsuda, Hideki, Mikami, Yasukazu, Tsukuda, Mamoru

“…Nafamostat mesilate (FUT-175), a synthetic serine protease inhibitor, has antitumor activities toward adenocarcinoma, e.g., colon cancer. However, its…”
Get full text

Oxidative stress marker 8-hydroxyguanosine is more highly expressed in prostate cancer than in benign prostatic hyperplasia by Ohtake, Shinji, Kawahara, Takashi, Ishiguro, Yukari, Takeshima, Teppei, Kuroda, Shinnosuke, Izumi, Koji, Miyamoto, Hiroshi, Uemura, Hiroji

“…Oxidative stress is a primary cause of vascular endothelial damage. In the prostate, ischemia increases the levels of reactive oxygen species, growth factors…”
Get full text

Antitumor effects of IDN5109 on head and neck squamous cell carcinoma by SANO, DAISUKE, MATSUDA, HIDEKI, ISHIGURO, YUKARI, NISHIMURA, GOSHI, KAWAKAMI, MARIKO, TSUKUDA, MAMORU

“…Oncol Rep 15: [Related article:] 329–334, 2006; DOI: 10.3892/or.15.2.329 After the publication of the article, the authors noted that the relevance of the…”
Get full text

Regulation of prostate cancer cell growth and PSA expression by angiotensin II receptor blocker with peroxisome proliferator-activated receptor gamma ligand like action by Ishiguro, Hitoshi, Ishiguro, Yukari, Kubota, Yoshinobu, Uemura, Hiroji

“…BACKGROUND We previously reported that angiotensin II (AII) activated the proliferation of prostate cancer cells, and its antagonist, an AII receptor type 1…”
Get full text

Antitumor effects of ZD6474 on head and neck squamous cell carcinoma by SANO, DAISUKE, KAWAKAMI, MARIKO, FUJITA, KYOKO, KIMURA, MACHIKO, YAMASHITA, YUKIKO, ISHIGURO, YUKARI, NISHIMURA, GOSHI, MATSUDA, HIDEKI, TSUKUDA, MAMORU

“…Oncol Rep 17: [Related article:] 289–295, 2007; DOI: 10.3892/or.17.2.289 After the publication of the article, the authors noted that the relevance of the…”
Get full text

Antitumor effects of telomelysin in combination with paclitaxel or cisplatin on head and neck squamous cell carcinoma by KONDO, Norio, TSUKUDA, Mamoru, KIMURA, Machiko, FUJITA, Kyoko, SAKAKIBARA, Atsuko, TAKAHASHI, Hideaki, ISHIGURO, Yukari, TOTH, Gabor, MATSUDA, Hideki

“…Telomelysin (OBP-301) is a telomerase-specific replication-component adenovirus. Telomelysin has a human telomerase reverse transcriptase (hTERT) promoter…”
Get full text

Anti-tumor effects of bevacizumab in combination with paclitaxel on head and neck squamous cell carcinoma by FUJITA, Kyoko, SANO, Daisuke, KIMURA, Machiko, YAMASHITA, Yukiko, KAWAKAMI, Mariko, ISHIGURO, Yukari, NISHIMURA, Goshi, MATSUDA, Hideki, TSUKUDA, Mamoru

“…Human tumors are dependent on angiogenesis for growth, and the vascular endothelial growth factor (VEGF) is a major regulator of this process. Bevacizumab…”
Get full text

Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma by KONDO, Norio, TSUKUDA, Mamoru, ISHIGURO, Yukari, KIMURA, Machiko, FUJITA, Kyoko, SAKAKIBARA, Atsuko, TAKAHASHI, Hideaki, TOTH, Gabor, MATSUDA, Hideki

“…The epidermal growth factor receptor (EGFR) and a related family member, HER-2, are often overexpressed simultaneously in patients with a variety of malignant…”
Get full text